SAN JOSE, Calif., July 23, 2019 /PRNewswire/ — Ablative Solutions, Inc., a company pioneering new approaches to the treatment of hypertension, today announced the enrollment and randomization of the first patient in the TARGET BP I global clinical trial. Piedmont Heart Institute in Atlanta is the first hospital center worldwide to enroll and randomize […]
Other News
SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent
TIANJIN, China, July 23, 2019 /PRNewswire/ — In a significant milestone toward obtaining key regulatory approvals for the BuMA Supreme Drug-Eluting Stent (DES) System, SINOMED has completed enrollment in the PIONEER III randomized, controlled clinical trial. The PIONEER III trial is designed to assess the safety and effectiveness of the BuMA Supreme […]
Penumbra Introduces Latest Stroke Thrombectomy Aspiration Technology at SNIS 2019
MIAMI–(BUSINESS WIRE)–Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. commercial availability of the Penumbra System’s most advanced technology – the Penumbra JET 7 Reperfusion Catheter with XTRA FLEX technology – at the Society of NeuroInterventional Surgery (SNIS) 16th Annual Meeting in Miami. Penumbra JET […]
ZOLL Acquires Mobilize RRS LLC.
CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, today announced it has acquired substantially all of the assets of Mobilize RRS LLC., of Pittsford, N.Y., a privately held company that markets the Mobilize Rescue Systems app and associated rescue kits, which are designed […]
Philips’ Second Quarter Results 2019
Philips delivers Q2 sales of EUR 4.7 billion, with 6% comparable sales growth and 8% comparable order intake growth; income from continuing operations increases to EUR 260 million and Adjusted EBITA margin improves to 11.8% Second-quarter highlights Sales in the quarter amounted to EUR 4.7 billion, with 6% comparable sales […]
EBR Systems Awarded Prestigious Forfait Innovation Package for WiSE CRT System by French Ministry of Social Affairs and Health
SUNNYVALE, Calif., July 22, 2019 /PRNewswire/ — EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced that the College of the French National Authority for Health (Haute Autorite de Sante, HAS) awarded a Forfait Innovation Package for the company’s WiSE™ Cardiac Resynchronization Therapy (CRT) System. […]
Total Brain Joins the American Heart Association’s Center for Health Technology & Innovation to Study Uses of Heart Rate Variability Data to Reduce Stress and Risk of Cardiovascular Incidents
SAN FRANCISCO, June 22, 2019 /PRNewswire/ — Total Brain, a neuroscience-based mental health and fitness platform, is joining the American Heart Association’s Center for Health Technology & Innovation’s (the Center) Innovators Network. The Association’s Center is focused on building and fostering health technologies and relationships in pursuit of innovative and scalable solutions across the healthcare […]
Amarin Announces $400,000,000 Public Offering of American Depositary Shares
BEDMINSTER, N.J. and DUBLIN, Ireland, July 17, 2019 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN) today announced that it has commenced an underwritten public offering of $400,000,000 of its American Depositary Shares pursuant to a shelf registration. All of the shares in the proposed offering are to be sold […]
MyoKardia Announces HCM Program Updates: Accelerates Timing for Mavacamten Topline Phase 3 Data; Re-acquires U.S. Royalty Rights to HCM Programs from Sanofi
SOUTH SAN FRANCISCO, Calif., July 18, 2019 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK) today announced updates related to its hypertrophic cardiomyopathy (HCM) treatment portfolio, including lead therapeutic candidate, mavacamten. Patient screening has closed for the Phase 3 EXPLORER-HCM registrational clinical study to assess the effect of mavacamten in treating […]
Olivier Chaudoir Joins BioSig as Director of Marketing
Westport, CT, July 18, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing technology platform designed to address an unmet need for the electrophysiology (EP) marketplace, today announced that Mr. Olivier Chaudoir joined the Company as Director of Marketing. Mr. Chaudoir brings to […]



